Page last updated: 2024-09-03

amarogentin and 9,10-dimethyl-1,2-benzanthracene

amarogentin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies

Compound Research Comparison

Studies
(amarogentin)
Trials
(amarogentin)
Recent Studies (post-2010)
(amarogentin)
Studies
(9,10-dimethyl-1,2-benzanthracene)
Trials
(9,10-dimethyl-1,2-benzanthracene)
Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene)
450356,01010772

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Das, A; Das, S; Mandal, S; Saha, P1

Other Studies

1 other study(ies) available for amarogentin and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model.
    Cancer letters, 2006, Dec-08, Volume: 244, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Caspase 3; Cell Proliferation; Cyclooxygenase 2; Disease Models, Animal; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Glucosides; In Situ Nick-End Labeling; Iridoids; Male; Medicine, Traditional; Membrane Proteins; Mice; Phytotherapy; Plant Extracts; Skin Neoplasms; Swertia; Up-Regulation

2006